Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Bio Essence (BIOE) over the last 6 years, with Q3 2025 value amounting to $56493.0.

  • Bio Essence's Total Non-Current Liabilities fell 9815.8% to $56493.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $56493.0, marking a year-over-year decrease of 9815.8%. This contributed to the annual value of $447414.0 for FY2024, which is 86803.05% up from last year.
  • According to the latest figures from Q3 2025, Bio Essence's Total Non-Current Liabilities is $56493.0, which was down 9815.8% from $156344.0 recorded in Q2 2025.
  • Bio Essence's 5-year Total Non-Current Liabilities high stood at $3.2 million for Q1 2025, and its period low was $46219.0 during Q4 2023.
  • For the 5-year period, Bio Essence's Total Non-Current Liabilities averaged around $1.2 million, with its median value being $1.3 million (2022).
  • Examining YoY changes over the last 5 years, Bio Essence's Total Non-Current Liabilities showed a top increase of 145399.39% in 2025 and a maximum decrease of 9815.8% in 2025.
  • Over the past 5 years, Bio Essence's Total Non-Current Liabilities (Quarter) stood at $1.4 million in 2021, then decreased by 10.47% to $1.2 million in 2022, then tumbled by 96.24% to $46219.0 in 2023, then surged by 868.03% to $447414.0 in 2024, then plummeted by 87.37% to $56493.0 in 2025.
  • Its Total Non-Current Liabilities stands at $56493.0 for Q3 2025, versus $156344.0 for Q2 2025 and $3.2 million for Q1 2025.